Log in to save to my catalogue

AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS...

AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100901450

AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

About this item

Full title

AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1899-1899

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Background:It has been postulated that advanced glycation end-products (AGEs) and their soluble receptor (sRAGE) could play a relevant role as inducers in the chronic inflammatory pathway in various conditions; among them, in immune-mediated diseases such as systemic lupus erythematosus (SLE). However, previous studies show conflicting results abou...

Alternative Titles

Full title

AB1134 SERUM ADVANCED GLYCATION END-PRODUCTS AND THEIR SOLUBLE RECEPTOR AS POTENTIAL NEW BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3100901450

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3100901450

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2024-eular.1212

How to access this item